The University of Southampton
University of Southampton Institutional Repository

Reprogramming the cellular response to hypoxia

Reprogramming the cellular response to hypoxia
Reprogramming the cellular response to hypoxia
HIF-1 is a heterodimeric transcription factor comprising HIF-1[alpha] and HIF-1[Beta] subunits. Cellular response to hypoxia relies on the dimerisation of HIF-1? and HIF-1? in the nucleus, forming HIF-1, which then initiates transcription of target genes. Both subunits are constitutively expressed, but the ? subunit is degraded in an oxygen-dependent manner, so it is only stabilised in hypoxia. HIF-1 expression is deregulated in many cancers and has been associated with resistance to chemotherapy. Therefore, understanding the molecular mechanisms of hypoxic response is key to developing cancer therapeutics.

This thesis describes the construction and validation of a novel method to study the HIF-1 pathway by reprogramming cellular behaviour. This is achieved by targeting HIF-1[alpha]/HIF-1[Beta] dimerisation with an endogenously expressed molecular inhibitor. The compound, cyclo-CLLFVY, was previously identified through screening of a library of biologically synthesised cyclic peptides. In this study, the peptide sequence was genetically-encoded, between split Nostoc punctiforme DnaE inteins, onto the chromosome of a mammalian cell line, to allow inducible expression and in situ cyclisation of the peptide. The utility of this methodology was demonstrated via identification of genes specifically transactivated by HIF-1 or HIF-2 transcription factors in hypoxia, in the integrated cell line. Furthermore, cell viability assays showed that specific inhibition of HIF-1 dimerisation in these cells increased cellular sensitivity to glucose deprivation and to inhibition of glycolysis.

In addition, the epigenetic regulation of HIF-1[alpha] was studied. HIF-1 transactivates the expression of its [alpha]-subunit resulting in positive autoregulation, which contributes to the build up of HIF-1[alpha] at the onset of hypoxia. This autoregulation is dependent on an unmethylated CpG site in the hypoxia response element (HRE) within the promoter of the HIF-1[alpha] gene. Given the key role of HIF-1 in the development of the mammalian embryo, the methylation status of the HIF-1[alpha] HRE in developing tissue was sought. The HIF-1[alpha] HRE was unmethylated in several embryonic tissues, suggesting that transactivation of HIF-1[alpha] plays a role in HIF-1-mediated gene expression during development.
Mistry, Ishna
70e94cae-a95e-44f8-b1f3-3218d6d278cf
Mistry, Ishna
70e94cae-a95e-44f8-b1f3-3218d6d278cf
Tavassoli, Ali
d561cf8f-2669-46b5-b6e1-2016c85d63b2

(2016) Reprogramming the cellular response to hypoxia. University of Southampton, Faculty of Natural and Environmental Sciences, Doctoral Thesis, 226pp.

Record type: Thesis (Doctoral)

Abstract

HIF-1 is a heterodimeric transcription factor comprising HIF-1[alpha] and HIF-1[Beta] subunits. Cellular response to hypoxia relies on the dimerisation of HIF-1? and HIF-1? in the nucleus, forming HIF-1, which then initiates transcription of target genes. Both subunits are constitutively expressed, but the ? subunit is degraded in an oxygen-dependent manner, so it is only stabilised in hypoxia. HIF-1 expression is deregulated in many cancers and has been associated with resistance to chemotherapy. Therefore, understanding the molecular mechanisms of hypoxic response is key to developing cancer therapeutics.

This thesis describes the construction and validation of a novel method to study the HIF-1 pathway by reprogramming cellular behaviour. This is achieved by targeting HIF-1[alpha]/HIF-1[Beta] dimerisation with an endogenously expressed molecular inhibitor. The compound, cyclo-CLLFVY, was previously identified through screening of a library of biologically synthesised cyclic peptides. In this study, the peptide sequence was genetically-encoded, between split Nostoc punctiforme DnaE inteins, onto the chromosome of a mammalian cell line, to allow inducible expression and in situ cyclisation of the peptide. The utility of this methodology was demonstrated via identification of genes specifically transactivated by HIF-1 or HIF-2 transcription factors in hypoxia, in the integrated cell line. Furthermore, cell viability assays showed that specific inhibition of HIF-1 dimerisation in these cells increased cellular sensitivity to glucose deprivation and to inhibition of glycolysis.

In addition, the epigenetic regulation of HIF-1[alpha] was studied. HIF-1 transactivates the expression of its [alpha]-subunit resulting in positive autoregulation, which contributes to the build up of HIF-1[alpha] at the onset of hypoxia. This autoregulation is dependent on an unmethylated CpG site in the hypoxia response element (HRE) within the promoter of the HIF-1[alpha] gene. Given the key role of HIF-1 in the development of the mammalian embryo, the methylation status of the HIF-1[alpha] HRE in developing tissue was sought. The HIF-1[alpha] HRE was unmethylated in several embryonic tissues, suggesting that transactivation of HIF-1[alpha] plays a role in HIF-1-mediated gene expression during development.

PDF
Ishna Mistry Thesis with corrections.pdf - Other
Download (38MB)

More information

Published date: 23 June 2016
Organisations: University of Southampton, Chemistry

Identifiers

Local EPrints ID: 397998
URI: http://eprints.soton.ac.uk/id/eprint/397998
PURE UUID: ad6cab92-5b74-4540-99c9-9b8c13d0ca94
ORCID for Ali Tavassoli: ORCID iD orcid.org/0000-0002-7420-5063

Catalogue record

Date deposited: 15 Jul 2016 12:27
Last modified: 23 Jun 2019 04:01

Export record

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×